Erythematotelangiectatic rosacea is a type of rosacea that causes a red face often with
frequent flushing, topical sensitivity and prominent blood vessels. We think that long term
damage to skin from the sun (photodamage) may play a role in causing this type of rosacea.
Tretinoin is a topical medication that is known to improve photodamage. We want to find out
if Atralin (tretinoin 0.05%) Gel used for up to 46 weeks will improve
erythematotelangiectatic rosacea (ETR).
Phase:
Phase 3
Details
Lead Sponsor:
Lisa E. Maier
Collaborators:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.